Compounds > 3-nitropropionic acid

3-nitropropionic acid and dronabinol

3-nitropropionic acid has been researched along with dronabinol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bizat, N; Boyer, F; Brouillet, E; Fernández-Ruiz, J; Hantraye, P; Lastres-Becker, I1
Appendino, G; Bellido, ML; Cantarero, I; Casano, S; Del Río, C; Ferreiro-Vera, C; Meyer, S; Morello, G; Muñoz, E; Nadal, X; Navarrete, C; Palomares, B; Sánchez-Carnerero, C1

Other Studies

2 other study(ies) available for 3-nitropropionic acid and dronabinol

ArticleYear
Potential involvement of cannabinoid receptors in 3-nitropropionic acid toxicity in vivo.
    Neuroreport, 2004, Oct-25, Volume: 15, Issue:15

    Topics: Animals; Autoradiography; Convulsants; Disease Models, Animal; Dopamine; Dronabinol; Drug Administration Schedule; Drug Interactions; gamma-Aminobutyric Acid; In Situ Hybridization; In Vitro Techniques; Male; Nitro Compounds; Propionates; Psychotropic Drugs; Rats; Rats, Inbred Lew; Receptor, Cannabinoid, CB1; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Striatonigral Degeneration; Succinate Dehydrogenase; Time Factors

2004
Tetrahydrocannabinolic acid is a potent PPARγ agonist with neuroprotective activity.
    British journal of pharmacology, 2017, Volume: 174, Issue:23

    Topics: Animals; Cannabis; Cell Line, Tumor; Disease Models, Animal; Dronabinol; Humans; Huntingtin Protein; Huntington Disease; Male; Mice; Mice, Inbred C57BL; Mitochondria; Neuroprotective Agents; Nitro Compounds; PPAR gamma; Propionates

2017